Topotecan Completed Phase 1 Trials for Malignancies / Solid Tumor Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00361803Topotecan Pharmacokinetic Characterization Study
NCT00193570Topotecan in Combination With Docetaxel in Refractory and/or Advanced Solid Tumors
NCT00193583Weekly Topotecan in Combination With Carboplatin in Two Different Schedules for Refractory and/or Advanced Solid Tumors